Rama K. Kethineni, MBBS

Rama Kethineni practices at Southeastern Dialysis Center Elizabethtown in Fayetteville, North Carolina.

Rama Kethineni's NPI, 1417226721, was assigned on December 16, 2011. Rama Kethineni holds North Carolina license 2023-02989.

Rama Kethineni's primary practice is Southeastern Dialysis Center Elizabethtown, at 557 Sandhurst Dr, Fayetteville, NC 28304 in Cumberland County. The practice phone is (910) 862-7022.

Rama Kethineni's primary practice is Southeastern Dialysis Center Elizabethtown in Fayetteville, North Carolina. Rama Kethineni is also affiliated with Cape Fear Valley Medical Center. The medical group on file is Carolina Kidney Care. Dmand AI also links Rama Kethineni to 2 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rama Kethineni practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Rama Kethineni's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Rama Kethineni's licenses on file in 4 states: North Carolina, Indiana, Ohio and Utah.

CMS data shows 1,070 Medicare services from Rama Kethineni across 11 procedure codes in 2024, for 386 Medicare patients. Medicare paid $96,795 for them.

CMS counts 386 Medicare patients who saw Rama Kethineni in 2024. The largest group is 75 to 84, with 134 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 4.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rama Kethineni's median patient age at 70, with 55% women.

In 2024, Rama Kethineni wrote 720 Medicare Part D claims for 238 patients. 88% of them were for generic drugs. CMS names the drug for 551 of them, across 19 drugs with 11 or more claims each, at $60,232 in total drug cost. In 2023, CMS named 1,609 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Rama Kethineni for performance year 2024, reported as part of a group. Rama Kethineni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rama Kethineni as offering telehealth.

Dmand AI links 1 paper to Rama Kethineni in 2022. Rama Kethineni's most frequent co-authors are Josephine D. Abraham, MD, Nirupama Mbbs Ramkumar, MD and Amara Sarwal, MD.

CMS Open Payments shows 70 general payments to Rama Kethineni from 19 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $258.